The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJtc Plc Regulatory News (JTC)

Share Price Information for Jtc Plc (JTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 907.00
Bid: 900.00
Ask: 903.00
Change: 15.00 (1.68%)
Spread: 3.00 (0.333%)
Open: 892.00
High: 907.00
Low: 889.00
Prev. Close: 907.00
JTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Committee Changes

26 Nov 2020 07:00

RNS Number : 4984G
JTC PLC
26 November 2020
 

 

26 November 2020

 

 

JTC PLC

(the "Company" and together with its subsidiaries "JTC" or the "Group")

 

Board Committee Changes

 

 

Nomination Committee Chair

 

In accordance with Listing Rule 9.6.11, JTC today announces that Dr. Erika Schraner, Non-Executive Director, will assume the role of Chair of the Nomination Committee, with immediate effect. Erika's appointment will be subject to her re-election by shareholders at the 2021 Annual General Meeting, the date of which is yet to be confirmed.

 

Erika has been a member of the Company's Nomination Committee since joining the JTC Board as a Non-executive Director on 18 November 2019. Her board-level roles, held since 2001, have included serving as an Advisory Board Member for eBoomerang (USA) and Freeon Ltd (UK) and a Non-Executive Director of Kevian Capital Management LLP, a San Francisco based global asset management firm with US$200m in hedge fund assets and US$1bn in advisory assets. Erika currently holds one other Non-Executive Director role with Amino Technologies PLC, whom she joined in 2019 and where she is also Chair of the Audit Committee and a member of the Nomination and the Remuneration Committees.

 

Erika succeeds Michael Gray, who has been Chair of the Nomination Committee since 8 March 2018. Michael remains a member of the Board and its Committees and will continue to fulfil the role of Chair of the Remuneration Committee.

 

Mike Liston, Non-Executive Chairman of the Board of Directors, said: "On behalf of the Board, I would like to thank Michael Gray for chairing the Nomination Committee since the Company's IPO, and look forward to welcoming Erika to the role."

 

Audit and Risk Committee Change

 

Pursuant to Listing Rule 9.6.11., JTC also announces that the Non-Executive Chairman, Mike Liston, has stepped down as a member of the Company's Audit and Risk Committee with immediate effect.

 

This change to the composition of the Audit and Risk Committee has been made to ensure that the Company is fully compliant with Provision 24 of the 2018 UK Corporate Governance Code.

 

Board Committees

 

Following these changes the membership of the Board Committees will be as set out below (the Remuneration Committee remaining unchanged):

 

· Audit and Risk Committee: Dermot Mathias (Chair), Michael Gray, Erika Schraner

· Nomination Committee: Erika Schraner (Chair), Mike Liston, Dermot Mathias, Michael Gray

· Remuneration Committee: Michael Gray (Chair), Mike Liston, Dermot Mathias, Erika Schraner

 

There have been no other changes to the information set out in LR 9.6.13R (2) to LR 9.6.13R (6). 

 

For further information please contact:

 

Miranda Lansdowne

JTC (Jersey) Limited

Company Secretary

+44 1534 700 000

Miranda.Lansdowne@jtcgroup.com

 

About JTC

 

JTC is an award-winning provider of fund, corporate and private client services. Founded in 1987, the company employs c.900 people across its global office network and is trusted to administer assets of c.US$130 billion.

 

JTC is committed to its shared ownership culture and philosophy, with management and staff holding over 20% of the equity in the firm, clearly aligning the interests of clients, employees and other stakeholders.

 

www.jtcgroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABABTTMTBTBPM
Date   Source Headline
24th Apr 20247:00 amRNSPDMR Shareholding
22nd Apr 20243:51 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSAcquisition of First Republic Trust Co of Delaware
18th Apr 20247:00 amRNSAnnual Financial Report and Notice of AGM
10th Apr 20247:00 amRNSVesting and Grant of Share Plan Awards
9th Apr 20247:00 amRNSFull year results for year ended 31 December 2023
20th Mar 20245:59 pmRNSHolding(s) in Company
4th Mar 20247:00 amRNSCompletion of Acquisition and Issue of Equity
29th Feb 202410:33 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSPre-close Full Year Trading Update
31st Jan 20247:00 amRNSTotal Voting Rights
12th Jan 20247:00 amRNSPayment of SALI earnout and issue of equity
12th Dec 20234:39 pmRNSTR1: Notification of Major Holdings
7th Dec 20237:00 amRNSHolding(s) in Company
24th Nov 20237:00 amRNSAcquisition of Blackheath Capital Management LLP
22nd Nov 202310:22 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
2nd Nov 20237:00 amRNSHolding(s) in Company
25th Sep 20237:00 amRNSDirector's Share Dealing
19th Sep 20237:00 amRNSPDMR's Share Dealing
12th Sep 20237:00 amRNSInterim results for the period ended 30 June 2023
1st Sep 20239:00 amRNSTotal Voting Rights
10th Aug 202310:42 amRNSHolding(s) in Company
9th Aug 20231:57 pmRNSHolding(s) in Company
3rd Aug 20237:00 amRNSCompletion of SDTC Acquisition and Issue of Equity
25th Jul 20237:00 amRNSInterim Trading Update and Notice of Results
21st Jun 20237:00 amRNSIssue of Equity and Voting Rights
20th Jun 20239:43 amRNSHolding(s) in Company
15th Jun 20237:00 amRNSResults of Placing
14th Jun 20234:36 pmRNSProposed Placing of New Ordinary Shares
14th Jun 20234:35 pmRNSAcquisition of South Dakota Trust Company
9th Jun 20239:43 amRNSHolding(s) in Company
31st May 20237:00 amRNSTotal Voting Rights
24th May 20238:12 amRNSResult of AGM
4th May 20237:00 amRNSIssue of Equity and Voting Rights
21st Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
12th Apr 20237:00 amRNSVesting and Grant of Performance Share Plan Awards
11th Apr 20237:00 amRNSFull year results for year ended 31 December 2022
7th Mar 20231:57 pmRNSHolding(s) in Company
13th Feb 202312:08 pmRNSHolding(s) in Company
2nd Feb 20237:00 amRNSPre-close Full Year Trading Update
14th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20222:52 pmRNSFormation of Governance and Risk Committee
1st Nov 20227:00 amRNSCompletion of NYPTC Acquisition
13th Sep 20227:00 amRNSInterim results for the period ended 30 June 2022
26th Aug 20227:00 amRNSProposed Acquisition of NYPTC
27th Jul 20227:00 amRNSEIP Award Vesting
22nd Jul 20227:00 amRNSPre-close Interim Update and Notice of Results
15th Jul 20227:00 amRNSNomination Committee Appointment
8th Jul 202211:43 amRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.